26th Feb 2013 16:05
26 February 2013
Dechra® Pharmaceuticals PLC
("Dechra" or "the Company")
Director / PDMR shareholding
Dechra Pharmaceuticals PLC has been notified that on 26 February 2013 the following transactions in respect of the Company's ordinary shares of 1 pence occurred:
Directors of the Company | Number of shares acquired ("Acquisition") | Price per share of shares acquired (£) | Total number of shares beneficially held following the Acquisition
| % of issued share capital beneficially held following the Acquisition |
Tony Griffin | 8,000
| 6.84 | 20,077 | 0.023% |
Julian Heslop | 5,000
| 6.84 | 5,000 | 0.006% |
Ishbel Macpherson | 2,897
| 6.84 | 2,897 | 0.003% |
For further information, please contact:
Zoe Goulding, Company Secretary
Telephone number: 01782 771100
About Dechra
Dechra is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
Related Shares:
DPH.L